Ureteral Cancer Withdrawn Phase 2 Trials for Mitometh (DB12117)

Also known as: Ureter Cancer / Ureteric cancer / Ureteric cancer NOS / Cancer of Ureter / Ureter Ca / Malignant neoplasm of ureter

DBCOND0034092 (Ureteral Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01639521Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerTreatment